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A mutation that affects the expression of spectinomycin resistance in a specti-
nomycin-resistant (spcA), conditionally asporogenic strain of Bacillus subtilis
has been designated srm (spectinomycin resistance modifier). This mutation
resulted in altered colony morphology and increased growth rate and sporulation
efficiency in the presence of spectinomycin.
Studies of bacterial mutants resistant to ri-
bosome-directed antibiotics have provided infor-
mation on the mechanism ofaction of antibiotics
and on the structure and function of the bacte-
rial ribosome (3, 10). Antibiotic-resistant mu-
tants of Bacillus subtilis have been used in
investigations of possible translational regula-
tion of sporulation (11). We have isolated spec-
tinomycin-resistant mutants of B. subtilis that
have alterations in their sporulation ability (2,
4). High-level spectinomycin resistance of B.
subtilis occurs by a spcA mutation, which causes
an alteration of ribosomal protein S5 (2, 7, 9).
This report describes a mutation that affects the
expression of a spcA mutation in B. subtilis.
Strain SPC1-11 contains a spontaneous spcA
mutation, resulting in a conditional sporulation
phenotype. Cultures of this strain grow vegeta-
tively in the presence of antibiotic and can spor-
ulate ui the absence of antibiotic, but do not
form spores in the presence of spectinomycin (2,
4). When grown on agar medium containing 100
,ug of spectinomycin per ml, strain SPCl-1l
forms small colonies, with smooth surfaces, and
even, circular edges. When a culture of SPCl-ll
was grown for five generations in the presence
ofspectinomycin and plated on medium contain-
ing antibiotic, 3% of the colonies were of a dif-
ferent colony morphology, being larger in size,
with rough surfaces and irregular edges. The two
colony types of SPCl-ll maintained their dis-
tinctive colony morphologies only when grown
on agar medium containing spectinomycin;
when grown on medium without antibiotic, both
types formed large colonies. Similar observa-
tions have been made by I. Smith with a differ-
ent spcA-containing strain (personal communi-
cation).
Figure 1 shows the effect of spectinomycin on
the exponential growth rate of SPC1-11 and one
large-colony variant of it, which was designated
strain SPC1-12. In the absence of antibiotic,
both strains grew at the same rate (generation
time = 45 min). In the presence of 100 ,ug of
spectinomycin per ml, the growth rate of SPCl-
11 was significantly decreased (generation time
= 110 min), whereas the effect on SPC1-12 was
much less severe (generation time = 55 min).
Both SPC1-11 and SPC1-12 grew and main-
tained the appropriate colony morphology on
medium containing up to 3 mg of spectinomycin
per ml, which was the highest concentration
tested. Neither SPC1-11 nor SPC1-12 showed
any cross-resistance to streptomycin.
SPC1-12 did not show the spectinomycin sen-
sitivity of sporulation of the parent strain. The
level of sporulation of SPC1-12 in the presence
of 100 jig of spectinomycin per ml was 80%
(determined by the method of Sterlini and Man-
delstam [12]). Sporulation of SPC1-11 under the
same conditions was 0.1%.
DNA from SPC1-11 and SPC1-12 was used to
transform strain 168 trp (wild type) to specti-
nomycin resistance (2). Transformants were
scored for colony morphology and for ability to
sporulate in the presence of spectinomycin with
agar plates of glutamic acid medium (1). On this
medium, sporulating (Sp') colonies ofB. subtilis
turn brown, but asporogenic (Sp-) colonies re-
main white (Table 1). When SPC1-11 was the
donor, all of the transformants were of the small
colony type, with spectinomycin-sensitive spor-
ulation. When SPC1-12 was the donor, trans-
formants were of both the large- and small-col-
ony types. All large-colony transformants were
able to sporulate in the presence of spectino-
mycin; all small-colony transformants had spec-
tinomycin-sensitive sporulation. DNA from sev-
eral of the large-colony-type transformants was
used to transform strain 168 trp to spectinomy-
cin resistance (Table 2). In each of the seven
transformation experiments, two classes of
transfornants resulted. The percentage of trans-












TABLE 2. Transformation of 168 trp to
spectinomycin resistance
No. of spectinomycin-resistant
Total no. transformants of type:
Donor DNA of tram- Smal Large % Large
formants colony colony colony
(Sp-) (Sp,) (Sp+)
1 193 90 103 53.4
2 202 110 92 45.5
3 180 89 91 50.5
4 210 109 101 48.1
5 210 117 93 44.3
6 249 146 103 41.1
7 187 109 78 41.7
Total for all 1431 770 661 46.2 (avg)
crosses
a Transfonrming DNA wag DreDared from each of
seven independent large-colony-type transformants
ha I I I I I I I I resulting from SPC1-12 x 168 trp.
1 2 3
TIME OUrNs )
FIG. 1. Exponential growth rate of SPCI-II and
SPCI-12 in the presence and absence of spectinomy-
cin. Cultures were grown in the medium of Sterlini
and Mandelstam (12). After exponential growth had
begun, spectinomycin was added to one culture of
each strain to a concentration of 100 pg/ml at zero
time. A parallel culture of each strain received no
antibiotic. Symbols: 0, SPC1-11, no spectinomycin;
0, SPC1-11 + 1X) pg of spectinomycin per ml; ,
SPC1-12, no spectinomycin; 0, SPC1-12 + 100 pg of
spectinomycin per ml. A5,,, absorbance at 500 nm.







SPCl-11 (small-colony type; Sp- 138 0
on spectinomycin)
SPC1-12 (large-colony type; Sp+ 270 182
on spectinomycin)
a Small colony and large colony refer to colony
morphology on agar plates containing spectinomycin.
approximately equal to that found in the original
cross with DNA from SPC1-12. These observa-
tions suggest that strain SPC1-12 contains a
second mutation, responsible for both the in-
creased growth rate and ability to sporulate in
the presence of spectinomycin. This mutation
probably does not in itself confer spectinomycin
resistance, and it can be genetically linked to the
spcA genetic marker. This mutation has been
designated srm, for spectinomycin resistance
modifier. If srm could confer Spcr by itself, then
some of the transformants from a SPC1-12 x
168 transformation would contain srm alone,
without the spcA marker. When those trans-
formants were used as donors of spectinomycin
resistance, only a single class of spectinomycin-
resistant transformants would result: large col-
ony, Sp' or Spc. Clearly, Table 2 shows this is
not the case with each of the seven transform-
ants tested.
Polyacrylamide gel electrophoresis (2) of the
ribosomal proteins of strain SPC1-12 showed
that this strain contains the altered 30S protein
resulting from the spcA mutation of the parent
strain. This protein alteration was also seen in
ribosomes from a large-colony-type transform-
ant from a SPC1-12 x 168 trp transfonnation
(Fig. 2). This result is consistent with the inter-
pretation that large-colony-type transformants
contain both the spcA spectinomycin resistance
mutation and the srm mutation. No difference
between the ribosomal proteins of SPC1-11 and
SPC1-12 could be detected in either the 30S or
50S ribosomal subunit (data not shown).
The spcA genetic marker of strain SPC1-11 is
located in a cluster of genes for ribosomal com-
ponents near cysA on the B. subtilis chromo-
some (2, 9, 10). The finding that the srm muta-
tion could be genetically linked to spcA with a
cotransformation frequency of 0.46 (Table 2)
suggested that this mutation might also be lo-
cated in that cluster of ribosomal genes. A trans-
formation cross was performed between SPC1-
12 (spcA srm) and OSB 192 (cysA). Selection
was for Cys+. Of 240 Cys+ transformants, 42
(17%) were spectinomycin resistant; 34 of these
were able to sporulate in the presence of specti-
nomycin. These results suggest that the srm





FIG. 2. Electrophoresis of the proteins of the 30S
ribosomal subunit from 168 trp, SPC1 -11, and a large-
colony-type transformant resulting from a SPC1-12
x 168 trp transformation. Salt-washed ribosomal
subunits were prepared, digested with RNase, and
electrophoresed atpH 4.3 in the presence of8M urea
(2). Each sample contains 0.85 absorbance units of
30S subunits at 260 nm. (A) 168 trp (wild type). (B)
Mixture of168 trp + SPC -1 1 . (C) SPCI - 1. (D) Large-
colony-type transformant from SPC1-12 x 168 trp.
since the cotransformation frequencies between
cysA and spcA (0.17) and between spcA and srm
(0.46) and the ability to genetically link cysA
and srm are inconsistent with a cysA-spcA-srm
gene order. srm was also mapped relative to the
str-1 mutation, which is located between cysA
and spcA on the chromosome (2, 10). A strain
with the str-1, spcA, and srm mutations was
constructed by transformation and used as the
source of DNA in a transformation with strain
SPC1-11 as the recipient. Of 150 streptomycin-
resistant transformants, 137 were able to sporu-
late in the presence of spectinomycin, giving a
cotransformation frequency between str-1 and
srm of 0.91. An attempt was made to deternine
the order of the str-1 and srm genetic markers
in additional mapping experiments. However,
due to the lack of reciprocity and additivity in
genetic maps constructed for this region of the
chromosome (2, 5, 10), and due to the tightness
of the linkage between srm and str-1, it was not
possible to order srm relative to str-1 (data not
shown). We have previously shown (2) that
when str-1 is the selected marker, the cotrans-
formation frequency between str-1 and spcA is
0.15. Therefore, str-1 is closer to srm than it is
to spcA. The order of these genetic markers is
cysA-(str-1-srm)-spcA, and srm is thus located
in the area of the chromosome that has been
shown to contain the genes coding for many
ribosomal components.
The srm mutation provides a new example of
the complex nature of antibiotic resistance
mechanisms. It has been shown that spectino-
mycin dependence in B. subtilis is the result of
two mutations, one conferring resistance (spcA)
and one making the resistant mutant drug de-
pendent (spcD) (6). Thus, srm represents a third
locus which can affect the response of B. subtilis
to spectinomycin. The interaction between srm
and spcA is similar to the functional interactions
that have been described for other pairs of
markers located in this region of the B. subtilis
chromosome (5, 10). It cannot be concluded that
the srm mutation is expressed only in the pres-
ence of a spcA mutation. There may be other
phenotypic differences caused by srm, not nec-
essarily related to spectinomycin resistance, but
these have not yet been identified. Whatever the
alteration caused by the srm mutation, it is able
to overcome some of the functional constraints,
including the inability to sporulate, imposed on
the spectinomycin-resistant, conditional strain
by the addition of antibiotic. Identification of
the component altered in a srm mutant could
prove to be a useful means of distinguishing
between some of the possible models for the
inability of the conditional strain to sporulate in
the presence of spectinomycin.
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